Journal article
High-Throughput Screen in Cryptococcus neoformans Identifies a Novel Molecular Scaffold That Inhibits Cell Wall Integrity Pathway Signaling
ACS infectious diseases, Vol.2(1), pp.93-102
01/08/2016
DOI: 10.1021/acsinfecdis.5b00111
PMID: 26807437
Abstract
Cryptococcus neoformans
is one of the most important
human fungal pathogens; however, no new therapies have been developed
in over 50 years. Fungicidal activity is crucially important for an
effective anticryptococal agent and, therefore, we screened 361,675
molecules against
C. neoformans
using an adenylate
kinase release assay that specifically detects fungicidal activity.
A set of secondary assays narrowed the set of hits to molecules that
interfere with fungal cell wall integrity and identified three benzothioureas
with low in vitro mammalian toxicity and good in vitro anticryptococcal
(minimum inhibitory concentration = 4 μg/mL). This scaffold
inhibits signaling through the cell wall integrity MAP kinase cascade.
Structure–activity studies indicate that the thiocarbonyl moiety
is crucial for activity. Genetic and biochemical data suggest that
benzothioureas inhibit signaling upstream of the kinase cascade. Thus,
the benzothioureas appear to be a promising new scaffold for further
exploration in the search for new anticryptococcal agents.
Details
- Title: Subtitle
- High-Throughput Screen in Cryptococcus neoformans Identifies a Novel Molecular Scaffold That Inhibits Cell Wall Integrity Pathway Signaling
- Creators
- Kate Hartland - Center for the Science of TherapeuticsJun Pu - Center for the Science of TherapeuticsMichelle Palmer - Center for the Science of TherapeuticsSivaraman Dandapani - Center for the Science of TherapeuticsPhilip N Moquist - Center for the Science of TherapeuticsBenito Munoz - Center for the Science of TherapeuticsLouis DiDone - Department of Pediatrics andStuart L Schreiber - Center for the Science of TherapeuticsDamian J Krysan - Department of Pediatrics and
- Resource Type
- Journal article
- Publication Details
- ACS infectious diseases, Vol.2(1), pp.93-102
- DOI
- 10.1021/acsinfecdis.5b00111
- PMID
- 26807437
- NLM abbreviation
- ACS Infect Dis
- ISSN
- 2373-8227
- eISSN
- 2373-8227
- Publisher
- American Chemical Society
- Grant note
- DOI: 10.13039/100000060, name: National Institute of Allergy and Infectious Diseases, award: 1R01AI091422, 1R01AI097142
- Language
- English
- Date published
- 01/08/2016
- Academic Unit
- Microbiology and Immunology; Stead Family Department of Pediatrics; Infectious Disease (Pediatrics)
- Record Identifier
- 9984093359602771
Metrics
12 Record Views